Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial-Reference-Cited by-同舟云学术

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial

Published:2018-03 Issue:10125 Volume:391 Page:1076-1084
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Papi Alberto,Vestbo Jørgen,Fabbri Leonardo,Corradi Massimo,Prunier Hélène,Cohuet Géraldine,Guasconi Alessandro,Montagna Isabella,Vezzoli Stefano,Petruzzelli Stefano,Scuri Mario,Roche Nicolas,Singh Dave

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. GOLD 2017 treatment pathways in ‘real life’: an analysis of the DACCORD observational study;Worth;Respir Med,2017

2. Understanding the GOLD 2011 Strategy as applied to a real-world COPD population;Vestbo;Respir Med,2014

3. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial;Singh;Lancet,2016

4. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial;Vestbo;Lancet,2017

5. Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD;Wedzicha;N Engl J Med,2016

Cited by 398 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisión narrativa de la terapia inhalatoria en la EPOC;Medicina de Familia. SEMERGEN;2024-10

2. A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: An Official American Thoracic Society Research Statement;American Journal of Respiratory and Critical Care Medicine;2024-09-15

3. Therapeutische Implikationen der Diagnose „small airway disease“;Zeitschrift für Pneumologie;2024-08-13

4. The Real-World Efficacy of Fixed Triple Inhalation Therapy in the Treatment of Moderate COPD Patients (RATIONALE Study);International Journal of Chronic Obstructive Pulmonary Disease;2024-08

5. Benefit–Harm Analysis of Earlier Initiation of Triple Therapy for Prevention of Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease;Annals of the American Thoracic Society;2024-08